All stock lists
Simmons First National Corp (NASDAQ:SFNC)
US · Delayed Price · Currency is USD
Financial Services · Banks - Regional
23.34+0.03 (+0.13%)
Market cap
$3.37B
Health Score
Analyst consensus
Listed since
Mar 14, 1985
Website
Insider Score
––Not scored
SFNC Insider Score
Insiders here have filed 16 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SFNC analyst forecast
SFNC analyst consensus
Hold4 ratings
Buy 2 Hold 1 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SFNC 12-month price target
$25.00+7.1% upsideaverage of 1 firm
$25.00High
$25.00Low
Best analysts covering SFNC
- Piper Sandler100%success rate · 2 calls
- Stephens & Co.33%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SFNC analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-10-19 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-10-19 |
| — | Morgan Stanley | Underweight | — | — | Reiterated | 2026-10-19 |
| Robert W. Baird | — | $25.00 | +13.3% | — | 2026-10-19 | |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Upgraded | 2026-09-10 |
| — | Morgan Stanley | Underweight | — | — | Downgraded | 2026-09-08 |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2026-09-04 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-09-04 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-07-20 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-07-20 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-07-17 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-06-29 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-04-20 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-04-17 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-03-31 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-01-22 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-01-22 |
| — | Raymond James | Outperform | — | — | Upgraded | 2026-01-22 |
| — | Baird | Outperform | — | — | Upgraded | 2025-11-19 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-10-20 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-07-23 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-07-21 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-07-21 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-04-21 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-04-21 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-01-23 |
| — | Stephens & Co. | Overweight | — | — | Upgraded | 2024-10-21 |
| — | Piper Sandler | Underweight | — | — | Reiterated | 2024-07-26 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-07-25 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2024-07-25 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2024-04-25 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-04-25 |
| — | Baird | Neutral | — | — | Reiterated | 2024-01-25 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2023-10-25 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2023-07-26 |
| — | Baird | Neutral | — | — | Reiterated | 2023-01-25 |
| — | Piper Sandler | Underweight | — | — | Downgraded | 2022-05-09 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2021-04-07 |
| — | Raymond James | Outperform | — | — | Reiterated | 2021-01-27 |
| — | DA Davidson | Neutral | — | — | Downgraded | 2020-10-20 |
| — | Baird | Neutral | — | — | Reiterated | 2020-10-20 |
| — | Raymond James | Outperform | — | — | Upgraded | 2020-06-17 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2020-01-24 |
| — | Sandler O'Neill | Buy | — | — | Upgraded | 2019-08-01 |
| — | Piper Sandler | Buy | — | — | Upgraded | 2019-08-01 |
| — | Sandler O'Neill | Buy | — | — | Upgraded | 2018-01-24 |
| — | Piper Sandler | Buy | — | — | Upgraded | 2018-01-24 |
| — | Sandler O'Neill | Hold | — | — | Downgraded | 2017-10-24 |
| — | Piper Sandler | Hold | — | — | Downgraded | 2017-10-24 |
| — | Raymond James | Underperform | — | — | Downgraded | 2017-01-25 |
| — | Keefe Bruyette & Woods | Market Perform | — | — | Downgraded | 2016-10-26 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Downgraded | 2016-10-26 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2016-06-08 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2016-06-08 |
| — | Piper Sandler | Hold | — | — | Downgraded | 2016-04-22 |
| — | Sandler O'Neill | Hold | — | — | Downgraded | 2016-04-22 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2016-02-29 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2016-02-29 |
| — | Keefe Bruyette & Woods | Outperform | — | — | Reiterated | 2015-01-26 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2015-01-26 |
SFNC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-04-16 | 0.47 | 0.47 | $243.1M | $241.4M |
| 2026-07-16 | 0.52 | 0.50 | $251.0M | $248.6M |
| 2026-10-15 | 0.54 | 0.54 | $254.0M | $251.2M |
| 2027-01-19 | 0.56 | 0.00 | $253.3M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.